Full Press Release Details
Zai Lab Limited to Announce Full Year 2017 Financial Results
SHANGHAI, China. April 24, 2018: Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative biopharmaceutical company, today
announced that it will host a conference call and webcast on Wednesday, May 2nd, 2018 at 8:30am ET to discuss financial results for the full year ended December 31, 2017. On the call, Zai
Lab s senior management team will also provide the latest status update on the Company s various development programs.
Date: Wednesday, May 2nd, 2018
Dial-In Details: 1-866-394-4355 (US); 1-314-888-4344 (International); 4006828609 (China)
Conference ID: 5836799
A live webcast and replay will
be available on the Zai Lab investor website: http://ir.zailaboratory.com. Please note, on Monday, April 30th, 2018 Zai Lab intends to file its Form 20-F for the Year Ended December 31, 2017.
Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and
infectious diseases to patients in China and around the world. The company s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing
segments of China s pharmaceutical market and global unmet medical needs. Zai Lab s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners and its own
products in order to impact human health worldwide.